NGS Based Diagnostics Market Report

Global NGS Based Diagnostics Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • POSTDATE：Jun 09, 2022
  • PAGES：176
  • REPORT CODE：GMM875900
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • NGS Based Diagnostics market report explains the definition, types, applications, major countries, and major players of the NGS Based Diagnostics market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Roche

    • Janssen

    • Illumina

    • iGenomX

    • Admera Health

    • AITbiotech

    • Paradigm Diagnostics

    • Innogene Kalbiotech

    • ThermoFisher Scientific

    • Qiagen

    • Pacific Biosciences

    • Oxford Gene Technology

    • Phalanx Biotech Group

    • Centogene

    By Type:

    • DNA Sequencing

    • RNA Sequencing

    • Whole Genome Sequencing

    • Whole Exome Sequencing

    • Other

    By End-User:

    • Hospitals

    • Clinics

    • Academics/Research Institutions

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global NGS Based Diagnostics Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 NGS Based Diagnostics Outlook to 2028- Original Forecasts

    • 2.2 NGS Based Diagnostics Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term NGS Based Diagnostics Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global NGS Based Diagnostics Market- Recent Developments

    • 6.1 NGS Based Diagnostics Market News and Developments

    • 6.2 NGS Based Diagnostics Market Deals Landscape

    7 NGS Based Diagnostics Raw Materials and Cost Structure Analysis

    • 7.1 NGS Based Diagnostics Key Raw Materials

    • 7.2 NGS Based Diagnostics Price Trend of Key Raw Materials

    • 7.3 NGS Based Diagnostics Key Suppliers of Raw Materials

    • 7.4 NGS Based Diagnostics Market Concentration Rate of Raw Materials

    • 7.5 NGS Based Diagnostics Cost Structure Analysis

      • 7.5.1 NGS Based Diagnostics Raw Materials Analysis

      • 7.5.2 NGS Based Diagnostics Labor Cost Analysis

      • 7.5.3 NGS Based Diagnostics Manufacturing Expenses Analysis

    8 Global NGS Based Diagnostics Import and Export Analysis (Top 10 Countries)

    • 8.1 Global NGS Based Diagnostics Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global NGS Based Diagnostics Export by Region (Top 10 Countries) (2017-2028)

    9 Global NGS Based Diagnostics Market Outlook by Types and Applications to 2022

    • 9.1 Global NGS Based Diagnostics Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global DNA Sequencing Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global RNA Sequencing Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Whole Genome Sequencing Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Whole Exome Sequencing Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Other Consumption and Growth Rate (2017-2022)

    • 9.2 Global NGS Based Diagnostics Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Clinics Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Academics/Research Institutions Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise NGS Based Diagnostics Market Analysis and Outlook till 2022

    • 10.1 Global NGS Based Diagnostics Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States NGS Based Diagnostics Consumption (2017-2022)

      • 10.2.2 Canada NGS Based Diagnostics Consumption (2017-2022)

      • 10.2.3 Mexico NGS Based Diagnostics Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany NGS Based Diagnostics Consumption (2017-2022)

      • 10.3.2 UK NGS Based Diagnostics Consumption (2017-2022)

      • 10.3.3 Spain NGS Based Diagnostics Consumption (2017-2022)

      • 10.3.4 Belgium NGS Based Diagnostics Consumption (2017-2022)

      • 10.3.5 France NGS Based Diagnostics Consumption (2017-2022)

      • 10.3.6 Italy NGS Based Diagnostics Consumption (2017-2022)

      • 10.3.7 Denmark NGS Based Diagnostics Consumption (2017-2022)

      • 10.3.8 Finland NGS Based Diagnostics Consumption (2017-2022)

      • 10.3.9 Norway NGS Based Diagnostics Consumption (2017-2022)

      • 10.3.10 Sweden NGS Based Diagnostics Consumption (2017-2022)

      • 10.3.11 Poland NGS Based Diagnostics Consumption (2017-2022)

      • 10.3.12 Russia NGS Based Diagnostics Consumption (2017-2022)

      • 10.3.13 Turkey NGS Based Diagnostics Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China NGS Based Diagnostics Consumption (2017-2022)

      • 10.4.2 Japan NGS Based Diagnostics Consumption (2017-2022)

      • 10.4.3 India NGS Based Diagnostics Consumption (2017-2022)

      • 10.4.4 South Korea NGS Based Diagnostics Consumption (2017-2022)

      • 10.4.5 Pakistan NGS Based Diagnostics Consumption (2017-2022)

      • 10.4.6 Bangladesh NGS Based Diagnostics Consumption (2017-2022)

      • 10.4.7 Indonesia NGS Based Diagnostics Consumption (2017-2022)

      • 10.4.8 Thailand NGS Based Diagnostics Consumption (2017-2022)

      • 10.4.9 Singapore NGS Based Diagnostics Consumption (2017-2022)

      • 10.4.10 Malaysia NGS Based Diagnostics Consumption (2017-2022)

      • 10.4.11 Philippines NGS Based Diagnostics Consumption (2017-2022)

      • 10.4.12 Vietnam NGS Based Diagnostics Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil NGS Based Diagnostics Consumption (2017-2022)

      • 10.5.2 Colombia NGS Based Diagnostics Consumption (2017-2022)

      • 10.5.3 Chile NGS Based Diagnostics Consumption (2017-2022)

      • 10.5.4 Argentina NGS Based Diagnostics Consumption (2017-2022)

      • 10.5.5 Venezuela NGS Based Diagnostics Consumption (2017-2022)

      • 10.5.6 Peru NGS Based Diagnostics Consumption (2017-2022)

      • 10.5.7 Puerto Rico NGS Based Diagnostics Consumption (2017-2022)

      • 10.5.8 Ecuador NGS Based Diagnostics Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain NGS Based Diagnostics Consumption (2017-2022)

      • 10.6.2 Kuwait NGS Based Diagnostics Consumption (2017-2022)

      • 10.6.3 Oman NGS Based Diagnostics Consumption (2017-2022)

      • 10.6.4 Qatar NGS Based Diagnostics Consumption (2017-2022)

      • 10.6.5 Saudi Arabia NGS Based Diagnostics Consumption (2017-2022)

      • 10.6.6 United Arab Emirates NGS Based Diagnostics Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria NGS Based Diagnostics Consumption (2017-2022)

      • 10.7.2 South Africa NGS Based Diagnostics Consumption (2017-2022)

      • 10.7.3 Egypt NGS Based Diagnostics Consumption (2017-2022)

      • 10.7.4 Algeria NGS Based Diagnostics Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia NGS Based Diagnostics Consumption (2017-2022)

      • 10.8.2 New Zealand NGS Based Diagnostics Consumption (2017-2022)

    11 Global NGS Based Diagnostics Competitive Analysis

    • 11.1 Roche

      • 11.1.1 Roche Company Details

      • 11.1.2 Roche NGS Based Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Roche NGS Based Diagnostics Main Business and Markets Served

      • 11.1.4 Roche NGS Based Diagnostics Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Janssen

      • 11.2.1 Janssen Company Details

      • 11.2.2 Janssen NGS Based Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Janssen NGS Based Diagnostics Main Business and Markets Served

      • 11.2.4 Janssen NGS Based Diagnostics Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Illumina

      • 11.3.1 Illumina Company Details

      • 11.3.2 Illumina NGS Based Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Illumina NGS Based Diagnostics Main Business and Markets Served

      • 11.3.4 Illumina NGS Based Diagnostics Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 iGenomX

      • 11.4.1 iGenomX Company Details

      • 11.4.2 iGenomX NGS Based Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 iGenomX NGS Based Diagnostics Main Business and Markets Served

      • 11.4.4 iGenomX NGS Based Diagnostics Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Admera Health

      • 11.5.1 Admera Health Company Details

      • 11.5.2 Admera Health NGS Based Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Admera Health NGS Based Diagnostics Main Business and Markets Served

      • 11.5.4 Admera Health NGS Based Diagnostics Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 AITbiotech

      • 11.6.1 AITbiotech Company Details

      • 11.6.2 AITbiotech NGS Based Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 AITbiotech NGS Based Diagnostics Main Business and Markets Served

      • 11.6.4 AITbiotech NGS Based Diagnostics Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Paradigm Diagnostics

      • 11.7.1 Paradigm Diagnostics Company Details

      • 11.7.2 Paradigm Diagnostics NGS Based Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Paradigm Diagnostics NGS Based Diagnostics Main Business and Markets Served

      • 11.7.4 Paradigm Diagnostics NGS Based Diagnostics Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 Innogene Kalbiotech

      • 11.8.1 Innogene Kalbiotech Company Details

      • 11.8.2 Innogene Kalbiotech NGS Based Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 Innogene Kalbiotech NGS Based Diagnostics Main Business and Markets Served

      • 11.8.4 Innogene Kalbiotech NGS Based Diagnostics Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 ThermoFisher Scientific

      • 11.9.1 ThermoFisher Scientific Company Details

      • 11.9.2 ThermoFisher Scientific NGS Based Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 ThermoFisher Scientific NGS Based Diagnostics Main Business and Markets Served

      • 11.9.4 ThermoFisher Scientific NGS Based Diagnostics Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    • 11.10 Qiagen

      • 11.10.1 Qiagen Company Details

      • 11.10.2 Qiagen NGS Based Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.10.3 Qiagen NGS Based Diagnostics Main Business and Markets Served

      • 11.10.4 Qiagen NGS Based Diagnostics Product Portfolio

      • 11.10.5 Recent Research and Development Strategies

    • 11.11 Pacific Biosciences

      • 11.11.1 Pacific Biosciences Company Details

      • 11.11.2 Pacific Biosciences NGS Based Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.11.3 Pacific Biosciences NGS Based Diagnostics Main Business and Markets Served

      • 11.11.4 Pacific Biosciences NGS Based Diagnostics Product Portfolio

      • 11.11.5 Recent Research and Development Strategies

    • 11.12 Oxford Gene Technology

      • 11.12.1 Oxford Gene Technology Company Details

      • 11.12.2 Oxford Gene Technology NGS Based Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.12.3 Oxford Gene Technology NGS Based Diagnostics Main Business and Markets Served

      • 11.12.4 Oxford Gene Technology NGS Based Diagnostics Product Portfolio

      • 11.12.5 Recent Research and Development Strategies

    • 11.13 Phalanx Biotech Group

      • 11.13.1 Phalanx Biotech Group Company Details

      • 11.13.2 Phalanx Biotech Group NGS Based Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.13.3 Phalanx Biotech Group NGS Based Diagnostics Main Business and Markets Served

      • 11.13.4 Phalanx Biotech Group NGS Based Diagnostics Product Portfolio

      • 11.13.5 Recent Research and Development Strategies

    • 11.14 Centogene

      • 11.14.1 Centogene Company Details

      • 11.14.2 Centogene NGS Based Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.14.3 Centogene NGS Based Diagnostics Main Business and Markets Served

      • 11.14.4 Centogene NGS Based Diagnostics Product Portfolio

      • 11.14.5 Recent Research and Development Strategies

    12 Global NGS Based Diagnostics Market Outlook by Types and Applications to 2028

    • 12.1 Global NGS Based Diagnostics Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global DNA Sequencing Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global RNA Sequencing Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global Whole Genome Sequencing Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.4 Global Whole Exome Sequencing Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.5 Global Other Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global NGS Based Diagnostics Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Clinics Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Academics/Research Institutions Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise NGS Based Diagnostics Market Analysis and Outlook to 2028

    • 13.1 Global NGS Based Diagnostics Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States NGS Based Diagnostics Consumption Forecast (2022-2028)

      • 13.2.2 Canada NGS Based Diagnostics Consumption Forecast (2022-2028)

      • 13.2.3 Mexico NGS Based Diagnostics Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany NGS Based Diagnostics Consumption Forecast (2022-2028)

      • 13.3.2 UK NGS Based Diagnostics Consumption Forecast (2022-2028)

      • 13.3.3 Spain NGS Based Diagnostics Consumption Forecast (2022-2028)

      • 13.3.4 Belgium NGS Based Diagnostics Consumption Forecast (2022-2028)

      • 13.3.5 France NGS Based Diagnostics Consumption Forecast (2022-2028)

      • 13.3.6 Italy NGS Based Diagnostics Consumption Forecast (2022-2028)

      • 13.3.7 Denmark NGS Based Diagnostics Consumption Forecast (2022-2028)

      • 13.3.8 Finland NGS Based Diagnostics Consumption Forecast (2022-2028)

      • 13.3.9 Norway NGS Based Diagnostics Consumption Forecast (2022-2028)

      • 13.3.10 Sweden NGS Based Diagnostics Consumption Forecast (2022-2028)

      • 13.3.11 Poland NGS Based Diagnostics Consumption Forecast (2022-2028)

      • 13.3.12 Russia NGS Based Diagnostics Consumption Forecast (2022-2028)

      • 13.3.13 Turkey NGS Based Diagnostics Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China NGS Based Diagnostics Consumption Forecast (2022-2028)

      • 13.4.2 Japan NGS Based Diagnostics Consumption Forecast (2022-2028)

      • 13.4.3 India NGS Based Diagnostics Consumption Forecast (2022-2028)

      • 13.4.4 South Korea NGS Based Diagnostics Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan NGS Based Diagnostics Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh NGS Based Diagnostics Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia NGS Based Diagnostics Consumption Forecast (2022-2028)

      • 13.4.8 Thailand NGS Based Diagnostics Consumption Forecast (2022-2028)

      • 13.4.9 Singapore NGS Based Diagnostics Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia NGS Based Diagnostics Consumption Forecast (2022-2028)

      • 13.4.11 Philippines NGS Based Diagnostics Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam NGS Based Diagnostics Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil NGS Based Diagnostics Consumption Forecast (2022-2028)

      • 13.5.2 Colombia NGS Based Diagnostics Consumption Forecast (2022-2028)

      • 13.5.3 Chile NGS Based Diagnostics Consumption Forecast (2022-2028)

      • 13.5.4 Argentina NGS Based Diagnostics Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela NGS Based Diagnostics Consumption Forecast (2022-2028)

      • 13.5.6 Peru NGS Based Diagnostics Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico NGS Based Diagnostics Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador NGS Based Diagnostics Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain NGS Based Diagnostics Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait NGS Based Diagnostics Consumption Forecast (2022-2028)

      • 13.6.3 Oman NGS Based Diagnostics Consumption Forecast (2022-2028)

      • 13.6.4 Qatar NGS Based Diagnostics Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia NGS Based Diagnostics Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates NGS Based Diagnostics Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria NGS Based Diagnostics Consumption Forecast (2022-2028)

      • 13.7.2 South Africa NGS Based Diagnostics Consumption Forecast (2022-2028)

      • 13.7.3 Egypt NGS Based Diagnostics Consumption Forecast (2022-2028)

      • 13.7.4 Algeria NGS Based Diagnostics Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia NGS Based Diagnostics Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand NGS Based Diagnostics Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of NGS Based Diagnostics

    • Figure of NGS Based Diagnostics Picture

    • Table Global NGS Based Diagnostics Import by Region (Top 10 Countries) (2017-2028)

    • Table Global NGS Based Diagnostics Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global DNA Sequencing Consumption and Growth Rate (2017-2022)

    • Figure Global RNA Sequencing Consumption and Growth Rate (2017-2022)

    • Figure Global Whole Genome Sequencing Consumption and Growth Rate (2017-2022)

    • Figure Global Whole Exome Sequencing Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals Consumption and Growth Rate (2017-2022)

    • Figure Global Clinics Consumption and Growth Rate (2017-2022)

    • Figure Global Academics/Research Institutions Consumption and Growth Rate (2017-2022)

    • Figure Global NGS Based Diagnostics Consumption by Country (2017-2022)

    • Table North America NGS Based Diagnostics Consumption by Country (2017-2022)

    • Figure United States NGS Based Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure Canada NGS Based Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure Mexico NGS Based Diagnostics Consumption and Growth Rate (2017-2022)

    • Table Europe NGS Based Diagnostics Consumption by Country (2017-2022)

    • Figure Germany NGS Based Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure UK NGS Based Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure Spain NGS Based Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure Belgium NGS Based Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure France NGS Based Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure Italy NGS Based Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure Denmark NGS Based Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure Finland NGS Based Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure Norway NGS Based Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure Sweden NGS Based Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure Poland NGS Based Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure Russia NGS Based Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure Turkey NGS Based Diagnostics Consumption and Growth Rate (2017-2022)

    • Table APAC NGS Based Diagnostics Consumption by Country (2017-2022)

    • Figure China NGS Based Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure Japan NGS Based Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure India NGS Based Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure South Korea NGS Based Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure Pakistan NGS Based Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh NGS Based Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure Indonesia NGS Based Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure Thailand NGS Based Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure Singapore NGS Based Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure Malaysia NGS Based Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure Philippines NGS Based Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure Vietnam NGS Based Diagnostics Consumption and Growth Rate (2017-2022)

    • Table South America NGS Based Diagnostics Consumption by Country (2017-2022)

    • Figure Brazil NGS Based Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure Colombia NGS Based Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure Chile NGS Based Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure Argentina NGS Based Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure Venezuela NGS Based Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure Peru NGS Based Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico NGS Based Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure Ecuador NGS Based Diagnostics Consumption and Growth Rate (2017-2022)

    • Table GCC NGS Based Diagnostics Consumption by Country (2017-2022)

    • Figure Bahrain NGS Based Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure Kuwait NGS Based Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure Oman NGS Based Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure Qatar NGS Based Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia NGS Based Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates NGS Based Diagnostics Consumption and Growth Rate (2017-2022)

    • Table Africa NGS Based Diagnostics Consumption by Country (2017-2022)

    • Figure Nigeria NGS Based Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure South Africa NGS Based Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure Egypt NGS Based Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure Algeria NGS Based Diagnostics Consumption and Growth Rate (2017-2022)

    • Table Oceania NGS Based Diagnostics Consumption by Country (2017-2022)

    • Figure Australia NGS Based Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure New Zealand NGS Based Diagnostics Consumption and Growth Rate (2017-2022)

    • Table Roche Company Details

    • Table Roche NGS Based Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Roche NGS Based Diagnostics Main Business and Markets Served

    • Table Roche NGS Based Diagnostics Product Portfolio

    • Table Janssen Company Details

    • Table Janssen NGS Based Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Janssen NGS Based Diagnostics Main Business and Markets Served

    • Table Janssen NGS Based Diagnostics Product Portfolio

    • Table Illumina Company Details

    • Table Illumina NGS Based Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Illumina NGS Based Diagnostics Main Business and Markets Served

    • Table Illumina NGS Based Diagnostics Product Portfolio

    • Table iGenomX Company Details

    • Table iGenomX NGS Based Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

    • Table iGenomX NGS Based Diagnostics Main Business and Markets Served

    • Table iGenomX NGS Based Diagnostics Product Portfolio

    • Table Admera Health Company Details

    • Table Admera Health NGS Based Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Admera Health NGS Based Diagnostics Main Business and Markets Served

    • Table Admera Health NGS Based Diagnostics Product Portfolio

    • Table AITbiotech Company Details

    • Table AITbiotech NGS Based Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

    • Table AITbiotech NGS Based Diagnostics Main Business and Markets Served

    • Table AITbiotech NGS Based Diagnostics Product Portfolio

    • Table Paradigm Diagnostics Company Details

    • Table Paradigm Diagnostics NGS Based Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Paradigm Diagnostics NGS Based Diagnostics Main Business and Markets Served

    • Table Paradigm Diagnostics NGS Based Diagnostics Product Portfolio

    • Table Innogene Kalbiotech Company Details

    • Table Innogene Kalbiotech NGS Based Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Innogene Kalbiotech NGS Based Diagnostics Main Business and Markets Served

    • Table Innogene Kalbiotech NGS Based Diagnostics Product Portfolio

    • Table ThermoFisher Scientific Company Details

    • Table ThermoFisher Scientific NGS Based Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

    • Table ThermoFisher Scientific NGS Based Diagnostics Main Business and Markets Served

    • Table ThermoFisher Scientific NGS Based Diagnostics Product Portfolio

    • Table Qiagen Company Details

    • Table Qiagen NGS Based Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Qiagen NGS Based Diagnostics Main Business and Markets Served

    • Table Qiagen NGS Based Diagnostics Product Portfolio

    • Table Pacific Biosciences Company Details

    • Table Pacific Biosciences NGS Based Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pacific Biosciences NGS Based Diagnostics Main Business and Markets Served

    • Table Pacific Biosciences NGS Based Diagnostics Product Portfolio

    • Table Oxford Gene Technology Company Details

    • Table Oxford Gene Technology NGS Based Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Oxford Gene Technology NGS Based Diagnostics Main Business and Markets Served

    • Table Oxford Gene Technology NGS Based Diagnostics Product Portfolio

    • Table Phalanx Biotech Group Company Details

    • Table Phalanx Biotech Group NGS Based Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Phalanx Biotech Group NGS Based Diagnostics Main Business and Markets Served

    • Table Phalanx Biotech Group NGS Based Diagnostics Product Portfolio

    • Table Centogene Company Details

    • Table Centogene NGS Based Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Centogene NGS Based Diagnostics Main Business and Markets Served

    • Table Centogene NGS Based Diagnostics Product Portfolio

    • Figure Global DNA Sequencing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global RNA Sequencing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Whole Genome Sequencing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Whole Exome Sequencing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Academics/Research Institutions Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global NGS Based Diagnostics Consumption Forecast by Country (2022-2028)

    • Table North America NGS Based Diagnostics Consumption Forecast by Country (2022-2028)

    • Figure United States NGS Based Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada NGS Based Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico NGS Based Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe NGS Based Diagnostics Consumption Forecast by Country (2022-2028)

    • Figure Germany NGS Based Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK NGS Based Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain NGS Based Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium NGS Based Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure France NGS Based Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy NGS Based Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark NGS Based Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland NGS Based Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway NGS Based Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden NGS Based Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland NGS Based Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia NGS Based Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey NGS Based Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC NGS Based Diagnostics Consumption Forecast by Country (2022-2028)

    • Figure China NGS Based Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan NGS Based Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure India NGS Based Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea NGS Based Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan NGS Based Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh NGS Based Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia NGS Based Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand NGS Based Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore NGS Based Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia NGS Based Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines NGS Based Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam NGS Based Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Table South America NGS Based Diagnostics Consumption Forecast by Country (2022-2028)

    • Figure Brazil NGS Based Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia NGS Based Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile NGS Based Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina NGS Based Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela NGS Based Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru NGS Based Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico NGS Based Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador NGS Based Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC NGS Based Diagnostics Consumption Forecast by Country (2022-2028)

    • Figure Bahrain NGS Based Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait NGS Based Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman NGS Based Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar NGS Based Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia NGS Based Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates NGS Based Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa NGS Based Diagnostics Consumption Forecast by Country (2022-2028)

    • Figure Nigeria NGS Based Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa NGS Based Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt NGS Based Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria NGS Based Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania NGS Based Diagnostics Consumption Forecast by Country (2022-2028)

    • Figure Australia NGS Based Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand NGS Based Diagnostics Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US